NASDAQ | ETF
Under normal circumstances, the Tema Neuroscience and Mental Health ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in neuroscience and mental health companies.
A company is generally considered to be a neuroscience or mental health company that derives at least 50% of revenues from neuroscience or neurology-related diseases, or mental health.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 10.48% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 7.77% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 6.29% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 5.05% |
| TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 5.01% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.87% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 4.37% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 4.05% |
| SYK | Stryker Corporation | Healthcare | Medical Devices | 3.33% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.22% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.13% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 2.63% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 2.59% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.57% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 2.47% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 2.43% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 2.17% |
| UCB | UCB SA | Healthcare | Biotechnology | 2.16% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 1.98% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 1.84% |